Samantha Shannon Bastow

Dr. Samantha Shannon Bastow


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2025 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
CAChinEn Ai
ChinEn Ai
MJMolly Jung
Molly Jung
SBSamantha Shannon Bastow
Samantha Shannon Bastow
GAGhislene Adjaoute
Ghislene Adjaoute
DBDavid Bostick
David Bostick
KYKalvin C. Yu
Kalvin C. Yu
Objective: To evaluate the hospital-reported cost of care, clinical burden, and incidence of hospital-onset bacteremia and fungemia (HOB) for hospital admissions with surgical site infections (SSI).Methods: A cross-sectional study of 38 acute-care hospital admissions with a procedure under the National Healthcare Safety Network (NHSN) surveillance for SSI was conducted. SSI admissions were identified through NHSN reporting by the hospital. Clinical outcomes were estimated for SSI compared to no SSI controls using propensity matching and multivariable adjusted models that controlled for patient and hospital demographics; these endpoints were also compared for SSI admissions with and without HOB co-occurrence.Results: The rate of hospital-reported SSI was 0.15 per 100 admissions with a procedure under surveillance for SSI. Admissions with SSI compared to no SSI had significantly higher incremental hospital-reported cost of $30,689 and length of stay (LOS) was 11.6 days higher. The incidence of HOB was 6-fold higher in admissions with SSI compared to no SSI. For SSI admissions with HOB vs. no HOB, HOB added $28,049 to cost of care and 6.5 days to the LOS.Conclusions: Hospital-reported SSIs were associated with higher clinical and economic burden. Patients with SSI and HOB had even more deleterious outcomes. These data may inform programs to augment infection prevention bundles targeting SSIs and downstream complications or comorbidities like HOB.

23 October 2024 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
KYKalvin C. Yu
Kalvin C. Yu
JOJohn C. O’hOro
John C. O’hOro
CAChinEn Ai
ChinEn Ai
MJMolly Jung
Molly Jung
SBSamantha Shannon Bastow
Samantha Shannon Bastow
Objective: This study quantified the burden of hospital-onset bacteremia and fungemia (HOB) among cancer and transplant patients compared to other patients.Methods: A retrospective cross-sectional study used data from 41 hospitals between October 2015 and June 2019. Hospitalizations were segmented into categories using diagnosis-related groups (DRG): myeloproliferative (MP) cancer, solid tumor cancer, transplant, and non-cancer/non-transplant (“reference group”). To quantify the association between DRG and HOB, multivariable adjusted Poisson regression models were fit. Analyses were stratified by length of stay (LOS).Results: Of 645,315 patients, 59% were female and the majority 41 years of age or older (76%). Hospitalizations with MP cancer and transplant demonstrated higher HOB burden compared to the reference group, regardless of LOS category. For all hospitalizations, the >30 days LOS category had a higher burden of HOB. The median time to reportable HOB was within 30 days regardless of duration of hospitalization (reference, 8 days; solid tumor cancer, 8 days; transplant, 12 days; MP cancer, 13 days).Conclusion: MP cancer and transplant patients had a higher burden of HOB compared to other hospitalized patients regardless of LOS. Whether these infections are preventable should be further evaluated to inform quality metrics involving reportable bacteremia and fungemia.

4 December 2024 in Pharmacy
Verified
Journal Article
Open access
PDF file
SBSamantha Shannon Bastow
Samantha Shannon Bastow
EBEric Borrelli
Eric Borrelli
JLJulia Lucaci
Julia Lucaci
HNHeather D Nelkin
Heather D Nelkin
AGApril Graves
April Graves
AHAmanda Hays
Amanda Hays
This study explored controlled substance (CS) diversion surveillance practices within hospital pharmacies across the United States. A survey with questions based on published CS diversion risk points was conducted in May 2024. A total of 66 participants from 31 states responded, with 54.5% from single facilities and the remaining from health systems. Most respondents were pharmacy directors, managers, or those in dedicated drug diversion roles. Over 70% have dedicated surveillance teams and use drug diversion software. Results highlight variation in practices, with larger institutions generally showing better compliance. Compliance in procurement and receiving was high for access measures; however, auditing of processes was lower. The lowest procurement compliance was in monitoring periodic automatic replacement (PAR) levels and validating orders with wholesalers. Storage practices showed high compliance in deploying cameras, but low compliance in monitoring them. Dispensing practices had high compliance for restricting CS in automated dispensing cabinets, but low incidence of witness verification during stocking. Waste and disposal practices were well-followed, but training on detecting potential signs of medication tampering was less common. The survey highlights that while strategies to prevent CS diversion exist, their implementation varies. Enhancing monitoring, auditing, and training is essential to strengthen diversion prevention efforts in hospital pharmacies.

15 March 2024 in American Journal of Pharmaceutical Education
Verified
Journal Article
Closed access
SBSamantha Shannon Bastow
Samantha Shannon Bastow
CGCraig Greszler
Craig Greszler

20 November 2025 in Journal of Nursing Education and Practice
Verified
Journal Article
Open access
PDF file
SBSamantha Shannon Bastow
Samantha Shannon Bastow
PFPatrick Farrer
Patrick Farrer
KDKrystal DeVaughn
Krystal DeVaughn
KYKalvin Yu
Kalvin Yu
Background and objective: As the practice of nursing requires broad clinical skills, it demands a wide range of understanding across many disciplines. To address nurse training and competency needs, health systems have implemented varying methods of skill development, including advanced technologies and virtual immersion strategies, in addition to the continuation of more conventional methods. The current literature remains limited in substantiating the effectiveness of a particular method. The objective of the study was to provide insights into the current post-licensure nurse training practice within U.S. health systems, nurse perceptions of training effectiveness for the given methods, and perceived gaps in nurse education. Methods: Design: A research survey of registered nurses across the United States. The survey was developed from published studies that describe the current training modalities deployed across U.S. health systems for nurses and based on direct feedback from practicing nurses. The survey was divided into the following sections: respondent demographics, commonly deployed training strategies, perceived effectiveness of different training methods, and perceived gaps in clinical practice training and competence. Results: A total of 247 nurse survey responses were included in the analysis. The results suggest that there is a disconnect between commonly deployed post-licensure nurse training strategies and the strategies that are perceived to be most valuable. There were several perceived gaps in core clinical nursing skills, highlighting an opportunity to improve upon current training strategies. Conclusions: This study provides insights into the current state of post-licensure nurse training and signals on where health systems may benefit from reassessing their educational strategies and where industry organizations may provide additional support by developing effective multi-modal education.

13 November 2025 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
SKSara Kurd-Misto
Sara Kurd-Misto
JRJustine Ross
Justine Ross
SBSamantha Shannon Bastow
Samantha Shannon Bastow
KYKalvin Yu
Kalvin Yu
SDSanjeet Dadwal
Sanjeet Dadwal
Objective: To evaluate the incidence of hospital-onset bacteremia and fungemia (HOB) among solid organ malignancy (SOM), hematologic malignancy (HM), and hematopoietic cell transplant (HCT) therapy patients at a large cancer care center. Methods: A single-center, observational, retrospective analysis was conducted for hospitalizations between January 1, 2018, and September 30, 2024, to identify patients with a first positive blood culture on or after day four of hospitalization. Hospitalizations were grouped into three categories: SOM, HM with HCT, and HM without HCT. The primary objective was to study the incidence of HOB. Secondary objectives: identification of risk factors for HOB events and pathogens associated with HOB events. Results: In 45,896 admissions, 1,470 HOB events were identified (incidence: 3.2%). The incidence of HOB was highest in the HM/HCT cohort (3.8%), followed by HM without HCT (2.3%) and SOM (0.9%). Risk factors of HOB identified included HM (OR 1.49), hospitalization within the past 90 days (OR 1.50), length of stay greater than or equal to 30 days (OR 6.74), intensive care unit (ICU) admission (OR 4.06), development of a CAUTI during admission (OR 23.23), or presence of a central line (OR 51.61). The most common pathogens were Escherichia coli (20.1%), coagulase-negative Staphylococci (19.0%), and Viridians streptococci (11.3%). Conclusion: This study highlights the high incidence of HOB among cancer and HCT patients. The risk factors and differential rates of HOB in subpopulations of this demographic may help to inform targeted infection prevention efforts in cancer centers.